Differentiate between acute and chronic or treated infection (test assesses the viability of the eggs) in patients with immunocompromised condition, pertinent travel history, exposure history or high pre-test probability for parasitic infection
Da Silva LC, Chieffi PP, Carrilho FJ.Schistosomiasis mansoni -- clinical features.Gastroenterol Hepatol. 2005;28(1):30-39. (Link to PubMed)
Fenwick A, Webster JP.Schistosomiasis: challenges for control, treatment and drug resistance.Curr Opin Infect Dis. 2006;19(6):577-582. (Link to PubMed)
Ross AG, Vickers D, Olds GR, Shah SM, McManus DP.Katayama syndrome.Lancet Infect Dis. 2007;7(3):218-224. (Link to PubMed)
Vennervald BJ, Dunne DW.Morbidity in schistosomiasis: an update.Curr Opin Infect Dis. 2004;17(5):439-447. (Link to PubMed)
Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA.Immunopathology of schistosomiasis.Immunol Cell Biol. 2007;85(2):148-154. (Link to PubMed)
Reviewed by
Carney, Heather, M.D. Assistant Medical Director, Transfusion Services at ARUP Laboratories; Pathology, University of Utah
Litwin, Christine, M.D. Medical Director, Immunology at ARUP Laboratories; Professor, Clinical Pathology, University of Utah
Petti, Cathy A., M.D. Medical Director, Infectious Diseases at ARUP Laboratories; Assistant Professor, Pathology and Medicine, University of Utah
Comprehensive Review: May 2008
Last Update: July 2008